Hiroshi Arakawa

4.1k total citations
80 papers, 3.2k citations indexed

About

Hiroshi Arakawa is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hiroshi Arakawa has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 28 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hiroshi Arakawa's work include T-cell and B-cell Immunology (26 papers), DNA Repair Mechanisms (20 papers) and Immune Cell Function and Interaction (15 papers). Hiroshi Arakawa is often cited by papers focused on T-cell and B-cell Immunology (26 papers), DNA Repair Mechanisms (20 papers) and Immune Cell Function and Interaction (15 papers). Hiroshi Arakawa collaborates with scholars based in Japan, United States and Germany. Hiroshi Arakawa's co-authors include Jean-Marie Buerstedde, Jean-Marie Buerstedde, Shunichi Takeda, Jessica Hauschild, Takeyuki Shimizu, Huseyin Saribasak, Hans-Reimer Rodewald, Horst Bluethmann, Minoru Takata and Hideo Yamagishi and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Hiroshi Arakawa

74 papers receiving 3.1k citations

Peers

Hiroshi Arakawa
Scott A. Ness United States
Irene M. Pedersen United States
T Nakagawa United States
Kelly G. Ten Hagen United States
Rachel M. Gerstein United States
Nicola Ternette United Kingdom
Hiroshi Arakawa
Citations per year, relative to Hiroshi Arakawa Hiroshi Arakawa (= 1×) peers Jean-Marie Buerstedde

Countries citing papers authored by Hiroshi Arakawa

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Arakawa more than expected).

Fields of papers citing papers by Hiroshi Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Arakawa. The network helps show where Hiroshi Arakawa may publish in the future.

Co-authorship network of co-authors of Hiroshi Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Arakawa. A scholar is included among the top collaborators of Hiroshi Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Arakawa. Hiroshi Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arakawa, Hiroshi. (2025). Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer. American Journal of Cancer Research. 15(1). 363–374.
2.
Wang, Huimin, Stéphane Poulain, Wenyu Cao, et al.. (2025). Palmitic acid induced the onset of lipotoxicity in a HepaSH-on-chip model with raised of H2O2 and IL-6, and altered p38/MAPK & JAK/STAT pathways. Toxicology. 520. 154345–154345.
3.
Arakawa, Hiroshi, Hiromi Miura, Rolen M. Quadros, Masato Ohtsuka, & Channabasavaiah B. Gurumurthy. (2024). Cross-contamination of CRISPR guides and other unrelated nucleotide sequences among commercial oligonucleotides. Nucleic Acids Research. 52(6). 3137–3145. 2 indexed citations
4.
Arakawa, Hiroshi, et al.. (2024). Three-dimensional culture of human proximal tubular epithelial cells for an in vitro evaluation of drug-induced kidney injury. Journal of Pharmaceutical Sciences. 113(11). 3255–3264. 2 indexed citations
6.
Komatsu, Shuhei, Takuma Ohashi, Jun Kiuchi, et al.. (2023). Plasma miR‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer. Cancer Science. 114(7). 3027–3040. 5 indexed citations
7.
Manabe, Y., et al.. (2019). A comparison of stroke distance error from dominant and non-dominant putting stance in professional and novice golfers. 7(1). 7732. 3 indexed citations
8.
Abe, Takuya, et al.. (2017). ESCO1/2's roles in chromosome structure and interphase chromatin organization. Genes & Development. 31(21). 2136–2150. 29 indexed citations
9.
Abe, Takuya, Masamichi Ishiai, M. Nurul Islam, et al.. (2014). Tumor suppressor RecQL5 controls recombination induced by DNA crosslinking agents. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(5). 1002–1012. 10 indexed citations
10.
Arakawa, Hiroshi, Hisaaki Kudo, Randolph B. Caldwell, et al.. (2007). Protein evolution by hypermutation and selection in the B cell line DT40. Nucleic Acids Research. 36(1). e1–e1. 36 indexed citations
11.
Arakawa, Hiroshi, et al.. (2006). A Role for PCNA Ubiquitination in Immunoglobulin Hypermutation. PLoS Biology. 4(11). e366–e366. 138 indexed citations
12.
Saribasak, Huseyin, et al.. (2006). Uracil DNA Glycosylase Disruption Blocks Ig Gene Conversion and Induces Transition Mutations. The Journal of Immunology. 176(1). 365–371. 67 indexed citations
13.
Arakawa, Hiroshi & Jean-Marie Buerstedde. (2006). DT40 gene disruptions: a how-to for the design and the construction of targeting vectors. Sub-cellular biochemistry. 40. 1–9. 7 indexed citations
14.
Arakawa, Hiroshi, Huseyin Saribasak, & Jean-Marie Buerstedde. (2004). Activation-Induced Cytidine Deaminase Initiates Immunoglobulin Gene Conversion and Hypermutation by a Common Intermediate. PLoS Biology. 2(7). e179–e179. 105 indexed citations
15.
Arakawa, Hiroshi, Alicja Z. Stasiak, Andrzej Kierzek, et al.. (2004). RDM1, a Novel RNA Recognition Motif (RRM)-containing Protein Involved in the Cell Response to Cisplatin in Vertebrates. Journal of Biological Chemistry. 280(10). 9225–9235. 27 indexed citations
16.
Yasuda, Masahiro, Shogo Tanaka, Hiroshi Arakawa, et al.. (2002). A comparative study of gut‐associated lymphoid tissue in calf and chicken. The Anatomical Record. 266(4). 207–217. 37 indexed citations
17.
Shimizu, Hiroshi, et al.. (1999). Functional pulmonary surfactant deficiency and neonatal respiratory disorders. Pediatric Pulmonology. 27(S18). 175–177. 3 indexed citations
18.
Arakawa, Hiroshi, Takeyuki Shimizu, & Shunichi Takeda. (1996). Re-evaluation of the probabilities for productive rearrangements on the κ andλloci. International Immunology. 8(1). 91–99. 46 indexed citations
19.
Takeda, Shunichi, Hans-Reimer Rodewald, Hiroshi Arakawa, Horst Bluethmann, & Takeyuki Shimizu. (1996). MHC Class II Molecules Are Not Required for Survival of Newly Generated CD4+ T Cells, but Affect Their Long-Term Life Span. Immunity. 5(3). 217–228. 327 indexed citations
20.
Kitao, Hiroyuki, Hiroshi Arakawa, Hideo Yamagishi, & Akira Shimizu. (1996). Chicken immunoglobulin μ-chain gene: germline organization and tandem repeats characteristic of class switch recombination. Immunology Letters. 52(2-3). 99–104. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026